Source:
@ARTICLE{Liang2005,
author = {Yu Liang and
Maximilian Diehn and Nathan Watson and Andrew W Bollen and Ken D Aldape and M.
Kelly Nicholas and Kathleen R Lamborn and Mitchel S Berger and David Botstein and Patrick O Brown and
Mark A Israel},
title = {Gene expression profiling reveals molecularly
and clinically distinct subtypes of glioblastoma multiforme.},
journal = {Proc Natl Acad Sci U S A},
year = {2005},
volume = {102},
pages = {5814--5819},
number = {16},
month = {Apr},
doi =
{10.1073/pnas.0402870102},
url =
{http://dx.doi.org/10.1073/pnas.0402870102}
}
Original data: http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE4058
Description:
Glioblastoma multiforme (GBM) is
the most common form of malignant glioma,
characterized by genetic instability, intratumoral histopathological variability, and unpredictable clinical
behavior. The authors investigated global gene expression in surgical samples
of brain tumors. Gene expression profiling revealed large
differences between normal brain samples and tumor tissues and between GBMs and lower-grade oligodendroglial
(ODG) tumors.
Parameters used in our filter: